亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

In vitro human muscarinic receptor binding assay

詳細技術說明
None
*Abstract
Many medications including certain antidepressants, antihistamines, antispasmodics, neuroleptics and antiarrythmics may cause anticholinergic side effects. These effects range from peripheral autonomic effects (dry mouth, constipation) to more serious central effects including cognitive impairment and delirium. Anticholinergic effects are cumulative and the elderly who take on average of three prescription medications are especially at risk for developing serious anticholinergic side effects. Our laboratory has developed an in vitro assay that measures the total serum anticholinergicity. This assay would be useful for drug discovery. It could determine if new therapeutic agents have anticholinergic properties.Available for non-exclusive license.
*Principal Investigation

Name: B. Richard Cumbie, Research Associate Sr

Department: Med-Psychiatry


Name: Margaret Kirshner, Laboratory Manager

Department: Med-Psychiatry


Name: Bruce Pollock

Department: Med-Psychiatry

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備